News & Events
Read our latest research news, explore upcoming events and find resources describing our mission and programs.
Latest News
NCATS Stories

Electronic Consent Summary Form Creates More Participant-Focused Process, Speeds Clinical Trial Enrollment
March 27, 2025 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Helping to End Addiction Long-term® Initiative (HEAL)
- Our Impact on Clinical Trials
An electronic consent summary form used for a clinical trial created a clearer and more efficient process and was well received by participants.
Read Article
NCATS Team Creates Novel Computational Pipeline to Find New Ways to Treat Glioblastoma
March 10, 2025 - NCATS News
- Analytical Chemistry
- Biomedical Data Translator (Translator)
- Informatics (IFX)
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
NCATS scientists tested a new method that could identify existing drugs effective against glioblastoma, a type of brain cancer that currently has no adequate treatments and a very low five-year survival rate.
Read ArticlePartner & Grantee News
NIH-Funded Cancer Drug Delivery Platform Continues Through Clinical Trials
March 27, 2025 - Grantee/Partner News
- Small Business (SBIR)
OU Researcher Leverages Technology for Alcohol Disorder Interventions in Primary Care
March 25, 2025 - Grantee/Partner News
- Our Impact on Tools and Technologies
Translator for Biomedical Research Aims to Speed Up Patient Care
March 25, 2025 - Grantee/Partner News
- Biomedical Data Translator (Translator)
Upcoming Events
NIH Rare Pair: Rare Disease Treatments Partnering Workshop
July 24, 2025 - July 25, 2025 - Workshop
Location: Mass General Brigham, Boston, Massachusetts
Join us for the NIH Rare Pair: Rare Disease Treatments Partnering Workshop, a pivotal event bringing together key contributors in the rare diseases ecosystem. Hosted by the National Institutes of Health (NIH), this workshop will take place July 24–25, 2025, at Mass General Brigham in Boston, Massachusetts.
This unique gathering will explore the rare diseases commercialization landscape from the diverse perspectives of industry leaders, private investors, government funders and patient advocacy organizations. Attendees will engage in dynamic panels and discussions addressing the challenges, opportunities and critical areas of interest in developing novel therapies for rare diseases.
Key highlights of the workshop include the following:
- Interactive Panels and Discussions: Gain insights into overcoming barriers and maximizing opportunities in the rare diseases treatment space.
- Rare Diseases Therapy Pitch Session: Listen to innovative NIH-supported investigators presenting cutting-edge treatments for rare diseases.
- Networking Opportunities: Build meaningful connections with researchers, investors and strategic partners driving advances in rare disease therapeutics.
Whether you’re a researcher, investor, advocate or industry professional, this workshop offers a unique opportunity to collaborate and accelerate the development of groundbreaking treatments for rare diseases.
Save the date and be part of the conversation that transforms ideas into treatments for patients with rare diseases.
Registration information and agenda will be coming soon.
Publications
Browse a listing of peer-reviewed scientific publications that feature research supported by NCATS programs and initiatives.
Matching Lines to Designs: A Novel Radiographic Index for Shorter Femoral Stems in Total Hip Arthroplasty
Clinical and Translational Science Awards (CTSA) Program - December 1, 2025 - Journal of Orthopaedics
Read PublicationOutcomes of Stretching Exercises After Lingual Frenotomy in Infants: A Prospective, Interventional Study
Clinical and Translational Science Awards (CTSA) Program - April 1, 2025 - International Journal of Pediatric Otorhinolaryngology
Read PublicationIntegrating Socioeconomic Deprivation Indices and Electronic Health Record Data to Predict Antimicrobial Resistance
Clinical and Translational Science Awards (CTSA) Program - March 28, 2025 - npj Antimicrobials and Resistance
Read PublicationTransvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross-Over Clinical Trial
Clinical and Translational Science Awards (CTSA) Program - March 26, 2025 - Neurourology and Urodynamics
Read PublicationAI-Guided Precision Parenteral Nutrition for Neonatal Intensive Care Units
Clinical and Translational Science Awards (CTSA) Program - March 25, 2025 - Nature Medicine
Read PublicationT-Cell Engagers in Multiple Myeloma: A Clinical Review
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - Blood and Lymphatic Cancer: Targets and Therapy
Read PublicationOptimal Dietary Patterns for Healthy Aging
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - Nature Medicine
Read PublicationEvolution of Clinical Health Information Exchanges to Population Health Resources: A Case Study of the Indiana Network for Patient Care
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - BMC Medical Informatics and Decision Making
Read PublicationOptimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Intervention Versus Waitlisted Group in African American Adults With Hypertension: A Randomized Control Trial Protocol
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - Nursing: Research and Reviews
Read PublicationCOVID-19 Vaccination Uptake in Ohio: Analyzing the Difference Between Metro and Non-Metro Residents
Clinical and Translational Science Awards (CTSA) Program - March 22, 2025 - BMC Public Health
Read Publication